When a sponsor with a Phase III melanoma study came to Worldwide, they faced rapid timelines in a highly competitive indication paired with a high site burden due to its selection criteria. How did Worldwide address these challenges? Find out in our case study: https://ow.ly/EZiS50Sxe36
Worldwide Clinical Trials
Research Services
Research Triangle Park, NC 162,402 followers
As a leading full-service global CRO, we work to create solutions that advance new treatments from discovery to reality.
About us
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.
- Website
-
http://www.worldwide.com
External link for Worldwide Clinical Trials
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Research Triangle Park, NC
- Type
- Privately Held
- Specialties
- Neuroscience/Central Nervous System Clinical Research, Rare Disease Clinical Research, Oncology - Solid Tumors Clinical Research, General Medicine Clinical Research, Cardiovascular and Metabolic Clinical Research, Rare Disease, Early Phase , and Clinical Trials
Locations
Employees at Worldwide Clinical Trials
Updates
-
Whether you’re interested in using biomarkers for exploratory research or as a primary endpoint measure, make sure to check out our comprehensive biomarker services today: https://ow.ly/Ehqc50Sx7Fj
Biomarker Fact Sheet
worldwide.com
-
GLP-1s are emerging as a breakthrough treatment for weight loss, but did you know the uses they can have for other indications? Find out the latest in GLP-1s, from challenges in medication usage to the future of these treatments, in our blog with MarieElena Cordisco, Scott Beasley, and Alexis Bailey: https://ow.ly/1baR50SyGqC
Current Clinical Research Trends in GLP-1 (Glucagon-Like Peptide 1) Treatment
worldwide.com
-
What does the shift towards nonaddictive pain management treatment look like? Recently, the clinical landscape has seen a considerable increase in clinical trials utilizing psychedelic agents for the treatment of chronic pain and other indications. Read more about this advancement in our white paper: https://ow.ly/HJKc50Sxcoj
The Art and the Science of Analgesia Research With Psychedelic Agents
worldwide.com
-
If you’re looking for practical solutions to complex and adaptive oncology trials and missed our james eamma’s presentation today at #CTOEastCoast, drop by Booth 21 or check out his recent webinar, available on demand! We’re onsite today and tomorrow at Clinical Trials in Onology East Coast and ready to discuss your trial! Packy W. Brown, Natalie Marra, Griffin Halpin https://ow.ly/cK6Y50Sy5rw
-
-
The oncology research landscape is rapidly evolving, and at Worldwide, we’re not just keeping up; we’re leading the way for you. Our latest report dives into the unique challenges and unmet needs in oncology clinical research, showcasing how our midsize CRO approach delivers stability and innovation where it’s most needed. Download your copy today: https://ow.ly/Ke1F50SxTl9
-
-
How can Worldwide support your metabolic dysfunction studies? Discover our full suite of MASH/MALD clinical development services in our fact sheet, from our core lab partnerships to global operational expertise: https://ow.ly/VyN550SwaQP
MASH/MASLD Clinical Development at Worldwide
worldwide.com
-
Want to hear about the latest cutting-edge initiatives reshaping oncology clinical trials? Discover FDA’s Project Optimus, novel study designs, and the impact of Bayesian models on drug development in our blog with Matt Cooper and james eamma: https://ow.ly/nU5150Sun6S
The Evolution of Oncology Trials: Project Optimus and Study Design Trends
worldwide.com
-
If you're in search for a bioanalytical partner to help advance your pre-clinical or clinical development program, look no further. Discover the bioanalytical difference at Worldwide! https://ow.ly/XziY50Sv484
Integrated Bioanalytical Lab in Austin, TX
worldwide.com
-
What fantastic news in the fight against obesity! Looking forward to making continuous advancements in metabolic research for conditions like NAFLD and MASLD.
Breaking News: The Treat and Reduce Obesity Act has passed the Ways and Means Committee! We extend our thanks to Chairman Congressman Jason Smith and all committee members who voted in favor. This legislation is a crucial first step in our ongoing fight against obesity, a major contributor to nonalcoholic fatty liver disease (NAFLD), now called metabolic dysfunction-associated steatotic liver disease (MASLD). This milestone is not just a win in the battle against obesity but also a beacon of hope for millions struggling with associated health conditions. Join us as we continue to push for meaningful change: https://alf.social/sys
-